Founded in September 2009, ARAHELIO is a diversified enterprise group, a national high-tech enterprise, mainly involved in biomedicine, medical devices, health products, cosmetics and skin care ingredients with a number of advanced technologies in the industry, dozens of technical patents, and with it’s own research & development bases and modern production bases. The current focus of research includes biological microcurrent signal extraction and identification, lung ultrasound, especially diaphragm ultrasound intelligence, Biosynthesis technology, human gene recombinant technology, new materials for skin management and refractory wound treatment, pulmonary nutrients, etc.

The team of skincare ingredients has built core resources such as human cell target database, bioactive raw material database, formula database, etc., and developed the targeted modification technology of bioactive raw materials with biosynthesis technology as the core, which has contributed to the synergistic efficiency of a variety of active raw materials in the process of compounding, and realized the coordinated optimization of efficacy, safety and mildness through multi-target synergy in human cells. We provide ingredients and formula customization services for many brands and manufacturers.

The skincare factory has also strong research and development and big production capacity from upstream gene technology, midstream peptide purification/short peptide synthesis technology and downstream vacuum freeze-drying technology, has an international GMPC standard pharmaceutical clean workshop, a dust-free workshop of 10,000 levels, and has advanced automated production equipment and a complete quality management system.